Pharma news
Americas
Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding. 10 October 2018
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out. 10 October 2018
Americas
North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware. 9 October 2018
Americas
The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association. 9 October 2018
Americas
US-based law firm O’Melveny has hired Hassen Sayeed as a partner in its IP and technology practice group in New York. 8 October 2018
Pharma
The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario. 4 October 2018
Americas
Patenting antibodies across different jurisdictions can be a difficult task, as Kathy Coulter, senior IP counsel at Bristol-Myers Squibb, tells LSIPR. 4 October 2018
Pharma
DLA Piper has appointed Marco de Morpurgo, from Allen & Overy, as a partner in the firm’s life sciences team in Rome, Italy. 3 October 2018
Pharma
Joseph Lenthall has joined Haseltine Lake as a partner, after spending more than a decade at Mewburn Ellis. 3 October 2018
Americas
Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system. 3 October 2018